TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026)
TerrAscend (TSNDF) reported Depreciation & Amortization (CF) of $4.1 million for Q1 2026, up 4.92% year-over-year from $3.9 million in Q1 2025, and up 4.6% quarter-over-quarter from $4.0 million in Q4 2025.
TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $4.1 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $4.1 million, up 4.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (up 17.14% YoY), and the FY2025 annual result was $15.6 million, up 7.32% from the prior year.
- Depreciation & Amortization (CF) rose to $4.1 million in Q1 2026 per TSNDF's latest filing, from $4.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $6.6 million in Q2 2022 and troughed at -$339000.0 in Q4 2023.
- A 5-year average of $4.2 million and a median of $4.1 million in 2026 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) plunged 106.72% in 2023, then surged 1043.36% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.0 million in 2022, then sank by 106.72% to -$339000.0 in 2023, then surged by 1043.36% to $3.2 million in 2024, then gained by 23.76% to $4.0 million in 2025, then climbed by 4.6% to $4.1 million in 2026.
- Business Quant data shows TSNDF's Depreciation & Amortization (CF) at $4.1 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | -339,000.00 |
| Dec 31, 2023 | -339,000.00 |